Advertisement

Hereditary Nephritis and Genetic Disorders

  • Farahnak Assadi

Abstract

A. Branchiootorenal syndrome B. Alport syndrome C. Alstrome syndrome D. Fechtner syndrome E. Nail-patella syndrome

Keywords

Autosomal Dominant Polycystic Kidney Disease Polycystic Kidney Disease Alport Syndrome Autosomal Recessive Polycystic Kidney Disease Nephritic Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Richardson D, Shires M, Davidson AM (2001) Renal diagnosis without renal biopsy. Nephritis and sensorineural deafness. Nephrol Dial Transplant 16:1291–1294CrossRefPubMedGoogle Scholar
  2. Bingham C, Ellard S, Cole TR, et al. (2002) Solitary kidney and diverse genital tract malformations associated with hepatocytes nuclear factor-1b mutations. Kidney Int 61: 1243–1251CrossRefPubMedGoogle Scholar
  3. Collin GB, Marshall PM, Ikeda A, et al. (2002) Mutations in ALMS1 cause obesity, Type 2 diabetes and neurosensory degeneration in Alstrom syndrome. Nat Genet 31:74–78PubMedGoogle Scholar
  4. Romio L, Wright V, Price K, et al. (2003) OFD1, the gene mutated in oral-facial-digital syndrome Type 1, is expressed in the metanephros and in human embryonic renal mesenchymal cells. J Am Soc Nephrol 14: 680–689CrossRefPubMedGoogle Scholar
  5. Hotta O, Inoue CN, Miyabayashi S, et al. (2001) Clinical and pathologic features of focal segmental glomerulosclerosis with mitochondrial tRNA Leu (UUR) gene mutation. Kidney Int 59:1236–1243CrossRefPubMedGoogle Scholar
  6. Bergmann C, Senderek J, Sedlacek B, et al. (2003) Spectrum of mutations in the genes for autosomal recessive polycystic kidney disease (ARPKD/PKHD1). J Am Soc Nephrol 14:76–89CrossRefPubMedGoogle Scholar
  7. Rossetti S, Torra R, Coto E, et al. (2003) A complete mutation screen of PKHD1 in autosomal recessive polycystic kidney disease pedigrees. Kidney Int 64:391–403CrossRefPubMedGoogle Scholar
  8. Badenas C, Praga M, Tazon B, et al. (2002) Mutations in the COL4A4 and COL4A3 gene cause familial benign hematuria. J Am Soc Nephrol 13:1248–1254PubMedGoogle Scholar
  9. Byrne MC, Budisavljevic MN, Fan Z, et al. (2002) Renal transplant in patients with Alport syndrome. Am J Kidney Dis 39:769–775CrossRefPubMedGoogle Scholar
  10. Mothes H, Heidet L, Arrondel C, et al. (2002) Alport syndrome associated with diffuse leiomyomatosis: COL4A5-COL4A6 deletion associated with a mild form of Alport nephropathy. Nephrol Dial Transplant 17:70–74CrossRefPubMedGoogle Scholar
  11. Nicolau C, Torra R, Badenas C et al. (1999) Autosomal dominant polycystic kidney disease Types 1 and 2: assessment of US sensitivity for diagnosis. Radiology 213:273–276PubMedGoogle Scholar
  12. Rossetti S, Chauveau D, Walker D, et al. (2002) A complete mutation screen of the ADPKD genes by DHPLC. Kidney Int 61:1588–1599CrossRefPubMedGoogle Scholar
  13. Zand MS, Stang J Dumalo M, et al. (2001) Screening a living donor kidney for polycystic kidney disease using heavily T2-weighted MRI. Am J Kidney Dis 38:612–619CrossRefGoogle Scholar
  14. Bergmann C, Senderek J, Selacek B, et al. (2003) Spectrum of mutations in the gene for autosomal recessive polycystic kidney disease (ARPKD/PKHD1). J Am Soc Nephrol 14:76–89CrossRefPubMedGoogle Scholar
  15. Maranchie JK, Linehan WM (2003) Genetic disorders and renal cell carcinoma. Urol Clin North Am 30:133–141CrossRefPubMedGoogle Scholar
  16. Rossetti S, Torra R, Coto E, et al. (2003) A complete mutation screen of PKHD1in autosomal recessive polycystic disease (ARPKD) pedigrees. Kidney Int 64:391–403CrossRefPubMedGoogle Scholar
  17. Singh AD, Shields CL, Shields JA (2001) von Hipple-Lindau disease. Survey of ophthalmology 46:117–142CrossRefPubMedGoogle Scholar
  18. Bertili R, Ginevri G, Dagnino M et al. (2003) Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin. Am J Kidney Dis 41: 1314–1321CrossRefGoogle Scholar
  19. Carraro M, Csridi G, Bruschi M et al. (2002). Serum glomerular permeability activity in patients with podocin mutations (NPHS2) and steroid-resistant nephritic syndrome. J Am Soc Nephrol 13:1946–1952CrossRefPubMedGoogle Scholar
  20. Guffon N (2003) Clinical manifestation in female patients with Fabry disease. J Med Genet 40: e38CrossRefPubMedGoogle Scholar
  21. Miliner DS, Wilson DM, Smith LH (2001). Phenotypic expression of primary hyperoxaluria: Comparative features of Types I and II Kidney Int 59:31–36Google Scholar
  22. Scheinman SJ (1998) X-linked hypercalciuric nephrolithiasis: Clinical syndromes and chloride channel mutations. Kidney Int 53:3–17CrossRefPubMedGoogle Scholar
  23. Barbey F, Joly D, Rieu O et al. (2000) Medical management of cystinuria: critical reappraisal of long-term results. J Urol 163:1419–1423CrossRefPubMedGoogle Scholar
  24. Blanchard A, Jeunemaitre X, Coudol P et al. (2001) Paracellin-1 is critical for magnesium and calcium reabsorption in the human thick ascending limb of Henle. Kidney Int 59:2206–2215PubMedGoogle Scholar
  25. Knrad M, Weber S (2003) Recent advances in molecular genetics of hereditary magnesium-losing disorders J Am Soc Nephrol 14:249–260CrossRefGoogle Scholar
  26. Praga M, Vara J, Gonzalez-Parra E, et al. (1995) Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Kidney Int 47:1419–425CrossRefPubMedGoogle Scholar
  27. Cruz DN, Shaer AJ, Bia MJ (2001) Gitleman’s syndrome revisited: an evaluation of symptoms and health-related quality of life. Kidney Int 59:710–717CrossRefPubMedGoogle Scholar
  28. Peters M, Jeck N, Reinalter S, et al. (2002) Clinical presentations of genetically defined patients with hypokalemic salt-losing tubulopathies. Am J Med 15:183–190CrossRefGoogle Scholar
  29. Bertelli R, Ginevri F, Caridi G, et al. (2003) Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin. Am J Kidney Dis 41: 1314–321CrossRefPubMedGoogle Scholar
  30. Carraro M, Caridi G, Bruschi M, et al. (2002) Serum glomerular permeability activity in patients with podocin mutations (NPHS2) and steroid-resistant nephritic syndrome. J Am Soc Nephrol 13:1946–1952CrossRefPubMedGoogle Scholar
  31. Karle SM, Uetz B, Ronner V, et al. (2002) Novel mutations in NPHS2 detected in both familial and sporadic steroid-resistant nephritic syndrome. I Am Soc Nephrol 13:388–393Google Scholar
  32. Tsukaguchi H, Sudhakar A, and Le TC, et al. (2002) NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele. J Clin Invest 110: 1659–1666PubMedGoogle Scholar
  33. Yorgin PD, Belson A, Higgins J, et al. (2001) Pulse methylprednisolone, cyclosporine, and ACE-inhibitor therapy decreases proteinuria in two siblings with familial focal segmental glomerulosclerosis. Am J Kidney Dis 37:e44CrossRefPubMedGoogle Scholar
  34. Strautnieks SS, Thompson RJ, Gardiner RM, et al. (1996) Anovel splice-site mutation in the gamma subunit of the epithelial sodium channel gene in three pseudohypoaldosteronism Type 1 families. Nat Genet 13:248–450CrossRefPubMedGoogle Scholar
  35. Mayan H, Vered I, Mouallem M, et al. (2002) Pseudohypoaldosteronism Type II: marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density. J Clin Endocrinol Metab 87:3248–3254CrossRefPubMedGoogle Scholar
  36. Geller DS, Rodriquez-Soriano J, Vallo Boado A, et al. (1998) Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism Type 1. Nat Genet 19:279–281CrossRefPubMedGoogle Scholar
  37. Hart TC, Gorry MC, Hart PS, et al. (2002) Mutations of the UMOD gene are responsible for medullary cystic kidney disease Type 2 and familial juvenile hyperuricemic nephropathy. J Med Genet 39:882–892CrossRefPubMedGoogle Scholar
  38. Karet FE (2002) Inherited distal renal tubular acidosis (2002) J Am Soc Nephrol 13:2178–2184CrossRefPubMedGoogle Scholar
  39. Alper SL (2002) Genetic diseases of acid-base transporters. Annu Rev Physiol 64:899–923CrossRefPubMedGoogle Scholar
  40. Karet FE (2002) Inherited distal renal tubular acidosis. J Am Soc Nephrol 13:2178–2184CrossRefPubMedGoogle Scholar
  41. Charnas LR, Bernardini I, Rader D, et al. (1991) Clinical and laboratory findings in the oculocerebrorenal syndrome of Low, with special reference to growth and renal function. N Engl J Med 324:1318–1325CrossRefPubMedGoogle Scholar
  42. Jais JP, Knebelman B, Giatras I, et al. (2000) X-linked Alport syndrome: Natural history in 195 families and genotype-phenotype correlations in males. J Am Soc Nephrol 11: 649–657PubMedGoogle Scholar
  43. Torra R, Badenas C, Perez-Oller L, et al. (2000) Increased prevalence of polycystic kidney disease Type 2 among elderly polycystic patients 36 :728–734Google Scholar
  44. Kaplan BS, Kaplan P, de Chadarevian JP et al. (1988) Variable expression of autosomal recessive polycystic kidney disease and congenital hepatic fibrosis within a family. Am J Med Gent 29:639–647CrossRefGoogle Scholar
  45. Betz R, Rensing C, Otto E, et al. (2000) Children with nephronophthisis. J Pediatr 136:828–831CrossRefPubMedGoogle Scholar
  46. Hildebrandt F, Jungers P, Robino C et al. (2001)Nephronophthisis and medullary cystic kidney disease and medullary sponge kidney disease, In: Diseases of Kidney, 7th, edited by Schrier R, Philadelphia, Lippincott, Williams and Wilkins, pp 521–528Google Scholar
  47. Cossart M, Eurin D, Didier F et al. (2004) Antenatal renal sonographic anomalies and postnatal follow-up of renal involvement in Bardet-Biedle syndrome. Ultrasound Obstet Gynecol 24:51–54CrossRefGoogle Scholar
  48. Cavaco BM, Guerra L, Bradley KJ (2004) Hyperparathyroidism-jaw tumor syndrome in Roma families from Portugal is due to a founder mutation of the HRPT2 gene. J Clin Endocrinol Metab 89:1747–1752CrossRefPubMedGoogle Scholar
  49. Koo B, Oh D, Chung SY (2002) Deficiency of von Willebrand factor-cleaving protease activity in the plasma of malignant patients. Thrombosis Re 105:471–476CrossRefGoogle Scholar
  50. Ruf RG, Lichtenberger A, Karle SM, et al. (2004) Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephritic syndrome. J AM Soc Nephrol 15: 722–732CrossRefPubMedGoogle Scholar
  51. Kashtan CE (2004) Familial hematuria due to Type IV collagen mutations: Alport syndrome and thin-basement membrane nephropathy. Curr Opin Pediatr 16:177–181CrossRefPubMedGoogle Scholar
  52. Muda AO, Massella L, Giannakakis K, et al. (2003) Confocal microscopy of the skin biopsy in the diagnosis of X-linked Alport syndrome. J Invest Dermatol 121:208–211CrossRefPubMedGoogle Scholar
  53. Gahl W, Thoene J, Schneider J (2002) Cystinosis. N Engl J Med 347:111–121CrossRefPubMedGoogle Scholar
  54. Konard M, Weber S (2003) Recent advances in molecular genetics of hereditary magnesium-losing disorders. J Am Soc Nephrol 14:249–260CrossRefGoogle Scholar
  55. Igarashi T, Sekine T, Inatomi J et al. (2002) Unraveling the molecular pathogenesis of isolated proximal renal tubular acidosis. J Am Soc Nephrol 13:2171–2177CrossRefPubMedGoogle Scholar
  56. Warnock DG (2001) Liddle syndrome: genetics and mechanisms of Na+ channel defects. Am J Med Sci 322:302–307CrossRefPubMedGoogle Scholar
  57. O’Shaughnessy KM, Karet FE (2004) Salt handling and hypertension. J Clin Invest 113: 1075–1081PubMedGoogle Scholar
  58. Hildebrandt F, Jungers P, Robino C, et al. (2001) Nephronophthisis and medullary cystic kidney disease and medullary sponge kidney disease, In: Diseases of Kidney, 7th ed, edited by Schrier R, Philadelphia, Lippincott, Williams and Wilkins, pp 521–528Google Scholar
  59. Hamed RMA, Shomaf M (2001) Congenital nephritic syndrome: a clinico-pathological study of thirty children. J Nephrol 14:104–109PubMedGoogle Scholar
  60. Donaldson MCD, Warner AA, Trompeter RS, et al. (1985) Familial juvenile nephronophthisis, Jeune’s syndrome and associated disorders. Arch Dis Child 60:426–434CrossRefPubMedGoogle Scholar
  61. Gruskin AB, Baluarte HJ, Cote ML, et al. (1974) The renal disease of thoracic asphyxiate dystrophy.Birth Defects 10:44–50Google Scholar
  62. Nagai T, Nishimura G, Kato R, et al. (1995) Del (12) (p11.21p12.2) associated with an asphyxiating thoracic dystrophy or chondroectodermal dysplasia-like syndrome. Am J Med Genet 55: 8–16CrossRefGoogle Scholar
  63. Stapleton FB, Johnson D, Kaplan GW, et al. (1980) The cystic renal lesion in tuberous sclerosis. J Pediatr 97:574–579CrossRefPubMedGoogle Scholar
  64. Stillwell TJ, Gomez MR, Kelias PP (1987) Renal lesions in tuberous sclerosis. J Urol 138:477–481PubMedGoogle Scholar
  65. Drash A, Sherman F, Hartmann WH, et al. (1970) A syndrome of psudo-hermaphroidism, wilm’s tumor, hypertension, and degenerative renal disease. J Pediatr 76:585–593CrossRefPubMedGoogle Scholar
  66. Hamed RMA, Shomaf M (2001) Congenital nephritic syndrome: a clinico-pathological study of thirty children. J Nephrol 14:104–109PubMedGoogle Scholar
  67. Schneller M, Braga SE, Moser H (1983) Congenital nephritic syndrome: clinico-pathological heterogeneity and prenatal diagnosis. Clin Nephrol 19:243–249PubMedGoogle Scholar
  68. Holland PC, Dillon JM, Pincott J, et al. (1983) hypoxanthine guanine phosphoribosyl-transferase deficiency presenting with gout and renal failure in infancy. Arch Dis Child 58:831–833CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Farahnak Assadi
    • 1
  1. 1.Rush University Medical CenterChicago

Personalised recommendations